Masimo announces U.S. release of Trace™ data visualization and reporting tool
IRVINE, Calif.— Masimo (NASDAQ: MASI) announced today the U.S. release of Trace™, patient data visualization and reporting software designed for Masimo Root® and Radical-7® monitors.
Trace is the first data visualization and reporting software compatible with the full capabilities of the Masimo Root Patient Monitoring and Connectivity Platform, including Radical-7 and Radius-7® Pulse CO-Oximeters®, Root with integrated noninvasive blood pressure and temperature, and connected MOC-9™ modules such as SedLine® brain function monitoring, ISA™ and ISA OR+ capnography, and O3® regional oximetry.
“Trace adds a valuable and powerful visualization resource to clinical toolkits,” said Joe Kiani, Founder and CEO of Masimo. “With its unique versatility and customizability and with access to all of Masimo’s advanced measurement technologies, Trace offers clinicians the ability to review and focus on the patient data patterns that matter most for each case, in the format that provides the most insight.”
Clinicians who are interested in reviewing overnight sleep studies and who review six-minute walk patient data can benefit from Trace’s ability to rapidly generate standard oximetry reports, as well as customized oximetry reports that also include acoustic respiration rate (RRa®) and end-tidal carbon dioxide (EtCO2) data. Clinicians and researchers can download and evaluate patient data involving advanced rainbow SET™ parameters and capnography, SedLine, and O3 measurements. Trace can display patient data from all of these technologies on the same time axis, facilitating clinical case review. The ability to annotate and store data helps clinicians build easily accessible case histories.
Trace can communicate with Masimo devices via high-speed wired or wireless connections, with the ability to download up to 96 hours of patient data in seconds, aiding workflow efficiencies. Trace can provide analytics such as the determination of the minimum, maximum, and mean values for each measurement, the percentage of time spent at defined parameter thresholds, threshold crossing counts, and the duration of desaturation events. Visual tools such as trend graphs, histograms, and event annotations are also supported. Data can be tagged with notes, labelled with identifiers, and cropped and adjusted to allow clinicians to focus on segments and items of interest, from which a PDF report can be generated or CSV file exported.
@MasimoInnovates | #Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care. In 1995, the company debuted Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to significantly reduce false alarms and accurately monitor for true alarms. Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,1 improve CCHD screening in newborns,2 and, when used for continuous monitoring with Masimo Patient SafetyNet™* in post-surgical wards, reduce rapid response activations and costs.3,4,5 Masimo SET® is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world,6 and is the primary pulse oximetry at 16 of the top 20 hospitals listed in the 2017-18 U.S. News and World Report Best Hospitals Honor Roll.7 In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), and more recently, Oxygen Reserve Index™ (ORi™), in addition to SpO2, pulse rate, and perfusion index (Pi). In 2014, Masimo introduced Root®, an intuitive patient monitoring and connectivity platform with the Masimo Open Connect™ (MOC-9™) interface, enabling other companies to augment Root with new features and measurement capabilities. Masimo is also taking an active leadership role in mHealth with products such as the Radius-7™ wearable patient monitor, iSpO2® pulse oximeter for smartphones, and the MightySat™ fingertip pulse oximeter. Additional information about Masimo and its products may be found at www.masimo.com.
Join the discussion
The comments below are member-generated and do not necessarily reflect the opinions of FireRescue1.com or its staff. If you cannot see comments, try disabling privacy and ad blocking plugins in your browser. All comments must comply with our Member Commenting Policy.